Journals / Turkish journal of physical medicine and rehabilitation / 2021 / Cilt: 67 - Sayı: 3

Effects of ultrasound-assisted botulinum neurotoxin-A injection in patients with bruxism and masseter hypertrophy

Pages
351–356
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: The MT decreases after a single dose of BoNT-A injection in patients with masseter muscle hypertrophy and ultrasonography is a convenient imaging modality for BoNT-A injection to the masseter.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: This study aims to explore effects of ultrasound-assisted injection of the botulinum neurotoxin-A (BoNT-A) on muscle thickness (MT) in patients with masseter hypertrophy.
📊
Key Findings & Data:Patients and methods: Between December 2018 and December 2019, a total of 20 patients (3 males, 17 females; mean age: 28±6.9 years; range, 18 to 42 years) with bruxism who underwent BoNT-A injections were reviewed retrospectively.
💡
Conclusion & Impact:Conclusion: The MT decreases after a single dose of BoNT-A injection in patients with masseter muscle hypertrophy and ultrasonography is a convenient imaging modality for BoNT-A injection to the masseter.
🔬Design:Review & Systematic Survey
📍Scope:2018 Verileri
⚙️Variables:Domain Parameters

Özet

Objectives: This study aims to explore effects of ultrasound-assisted injection of the botulinum neurotoxin-A (BoNT-A) on muscle thickness (MT) in patients with masseter hypertrophy. Patients and methods: Between December 2018 and December 2019, a total of 20 patients (3 males, 17 females; mean age: 28±6.9 years; range, 18 to 42 years) with bruxism who underwent BoNT-A injections were reviewed retrospectively. The patients were treated using individualized injection dosages and sites. Assessment methods included length between the tragus and the angle of the mouth, maximal bite force, and MT of the masseter muscle. Follow-up data were collected from the hospital electronic database. Results: There were 26 masseter muscles with masseter hypertrophy in 20 patients. There was a significant difference in ultrasonographic measurements of the relaxed and contracted masseter muscles between the baseline and two weeks, one month and three months after the treatment (p 0.05). Conclusion: The MT decreases after a single dose of BoNT-A injection in patients with masseter muscle hypertrophy and ultrasonography is a convenient imaging modality for BoNT-A injection to the masseter.

🔖

Cite This Article

DIRAÇOĞLU, D., ŞAHBAZ, T., ALPTEKİN, H. K., DOĞAN, N. (2021). Effects of ultrasound-assisted botulinum neurotoxin-A injection in patients with bruxism and masseter hypertrophy. Turkish journal of physical medicine and rehabilitation, Cilt: 67 - Sayı: 3, 351–356. https://ajindex.com/articles/408564

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Yap AU, Chua AP. Sleep bruxism: Current knowledge and contemporary management. J Conserv Dent 2016;19:383-9
  2. Katsetos CD, Bianchi MA, Jaffery F, Koutzaki S, Zarella M, Slater R. Painful unilateral temporalis muscle enlargement: Reactive masticatory muscle hypertrophy. Head Neck Pathol 2014;8:187-93
  3. Shetty N, Malaviya RK, Gupta MK. Management of unilateral masseter hypertrophy and hypertrophic scar-a case report. Case Rep Dent 2012;2012:521427
  4. Arzul L, Corre P, Khonsari RH, Mercier JM, Piot B. Asymmetric hypertrophy of the masticatory muscles. Ann Chir Plast Esthet 2012;57:286-91
  5. Kebede B, Megersa S. Idiopathic masseter muscle hypertrophy. Ethiop J Health Sci 2011;21:209-12
  6. De la Torre Canales G, Câmara-Souza MB, do Amaral CF, Garcia RC, Manfredini D. Is there enough evidence to use botulinum toxin injections for bruxism management? A systematic literature review. Clin Oral Investig 2017;21:727-34
  7. Awan KH. The therapeutic usage of botulinum toxin (Botox) in non-cosmetic head and neck conditions - An evidence based review. Saudi Pharm J 2017;25:18-24
  8. Al-Wayli H. Treatment of chronic pain associated with nocturnal bruxism with botulinum toxin. A prospective and randomized clinical study. J Clin Exp Dent 2017;9:e112-e117
  9. Tinastepe N, Küçük BB, Oral K. Botulinum toxin for the treatment of bruxism. Cranio 2015;33:291-8
  10. Quezada-Gaon N, Wortsman X, Peñaloza O, Carrasco JE. Comparison of clinical marking and ultrasound-guided injection of Botulinum type A toxin into the masseter muscles for treating bruxism and its cosmetic effects. J Cosmet Dermatol 2016;15:238-44
  11. To EW, Ahuja AT, Ho WS, King WW, Wong WK, Pang PC, et al. A prospective study of the effect of botulinum toxin A on masseteric muscle hypertrophy with ultrasonographic and electromyographic measurement. Br J Plast Surg 2001;54:197-200
  12. Pizolato RA, Gavião MB, Berretin-Felix G, Sampaio AC, Trindade Junior AS. Maximal bite force in young adults with temporomandibular disorders and bruxism. Braz Oral Res 2007;21:278-83
  13. Mäntyvaara J, Sjöholm T, Kirjavainen T, Waltimo A, Iivonen M, Kemppainen P, et al. Altered control of submaximal bite force during bruxism in humans. Eur J Appl Physiol Occup Physiol 1999;79:325-30
  14. Cosme DC, Baldisserotto SM, Canabarro Sde A, Shinkai RS. Bruxism and voluntary maximal bite force in young dentate adults. Int J Prosthodont 2005;18:328-32
  15. Dıraçoğlu D, Alptekin K, Cifter ED, Güçlü B, Karan A, Aksoy C. Relationship betw